HCaRG is a novel regulator of renal epithelial cell growth and differentiation causing G2M arrest

American Journal of Physiology - Renal Physiology

Volumn 284, Issue 4 53-4, 2003, Pages

  Devlin, Alison M ^a   Solban, Nicolas ^a   Tremblay, Sandra ^a   Gutkowska, Jolanta ^a   Schürch, Walter ^a   Orlov, Sergei N ^a   Lewanczuk, Richard ^b   Hamet, Pavel ^a   Tremblay, Johanne ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Calcium regulated gene; Human embryonic kidney 293 cells; Hypertension related; Novel gene; p21Cip1 WAF1; p27Kip1 atrial natriuretic peptide

Indexed keywords

ATRIAL NATRIURETIC FACTOR; GENE PRODUCT; MESSENGER RNA; PROTEIN HCALPHARG; PROTEIN P21; PROTEIN P27; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G2 PHASE; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL SIZE; CHROMOSOME MAP; CLONE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE LOCUS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; KIDNEY EPITHELIUM; MITOSIS INHIBITION; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN CONTENT;

EID: 0037376686     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00252.2002     Document Type: Article

References (34)

1. Braun-Dullaeus RC, Mann MJ, Ziegler A, von der Leyen HE, and Dzau VJ. A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy. J Clin Invest 104: 815-823, 1999.
2. Bub A, Rechkemmer G, Hock D, and Forssmann WG. Secretion of a urodilatin-like immunoreactive (URO-like-IR) substance from a human kidney cell line (HEK-293). Eur J Med Res 1: 479-483, 1996.
3. Champagne MJ, Dumas P, Orlov SN, Bennett MR, Hamet P, and Tremblay J. Protection against necrosis but not apoptosis by heat-stress proteins in vascular smooth muscle cells: evidence for distinct modes of cell death. Hypertension 33: 906-913, 1999.
4. Davidowitz EJ, Schoenfeld AR, and Burk RD. VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling. Mol Cell Biol 21: 865-874, 2001.
5. Day ML, Schwartz D, Wiegand RC, Stockman PT, Brunnert SR, Tolunay HE, Currie MG, Standaert DG, and Needleman P. Ventricular atriopeptin. Unmasking of messenger RNA and peptide synthesis by hypertrophy or dexamethasone. Hypertension 9: 485-491, 1987.
6. de Bold AJ, Borenstein HB, Veress AT, and Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28: 89-94, 1981.
7. Devlin AM, Brosnan MJ, Graham D, Morton JJ, McPhaden AR, McIntyre M, Hamilton CA, Reid JL, and Dominiczak AF. Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo. Am J Physiol Heart Circ Physiol 274: H52-H59, 1998.
8. Dinev D, Jordan BW, Neufeld B, Lee JD, Lindemann D, Rapp UR, and Ludwig S. Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO J 2: 829-834, 2001.
9. 2/M arrest. Mol Endocrinol 13: 1738-1750, 1999.
10. Gobe G, Willgoss D, Hogg N, Schoch E, and Endre Z. Cell survival or death in renal tubular epithelium after ischemiareperfusion injury. Kidney Int 56: 1299-1304, 1999.
11. Gutkowska J, Jankowski M, Mukaddam-Daher S, and McCann SM. Corticotropin-releasing hormone causes antidiuresis and antinatriuresis by stimulating vasopressin and inhibiting atrial natriuretic peptide release in male rats. Proc Natl Acad Sci USA 97: 483-488, 2000.
12. Gutkowska J, Nemer M, Sole MJ, Drouin J, and Sirois P. Lung is an important source of atrial natriuretic factor in experimental cardiomyopathy. J Clin Invest 83: 1500-1504, 1989.
13. Hadrava V, Tremblay J, and Hamet P. Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats. Hypertension 13: 589-597, 1989.
14. Hamet P, Pausova Z, Dumas P, Sun YL, Tremblay J, Pravenec M, Kunes J, Krenova D, and Kren V. Newborn and adult recombinant inbred strains: a tool to search for genetic determinants of target organ damage in hypertension. Kidney Int 53: 1488-1492, 1998.
15. Hannken T, Schroeder R, Stahl RA, and Wolf G. Atrial natriuretic peptide attenuates ANG II-induced hypertrophy of renal tubular cells. Am J Physiol Renal Physiol 281: F81-F90, 2001.
16. Lenz W, Herten M, Gerzer R, and Drummer C. Regulation of natriuretic peptide (urodilatin) release in a human kidney cell line. Kidney Int 55: 91-99, 1999.
17. Logan JL and Michael UF. Atrial natriuretic peptide suppresses compensatory renal growth in rats. J Am Soc Nephrol 4: 2016-2022, 1994.
18. Lowry O, Rosebrouh N, Farr A, and Randall RJ. Protein measurement with the Folin reagent. J Biol Chem 193: 265-275, 1951.
19. 2-M. Cancer Res 53: 1328-1331, 1993.
20. McKenzie JC, Scott JN, and Inagami T. Immunohistochemical localization of atrial natriuretic peptide in the developing and adult mammalian kidney. Am J Anat 190: 182-191, 1991.
21. Naraghi S, Khoshyomn S, DeMattia JA, and Vane DW. Receptor tyrosine kinase inhibition suppresses growth of pediatric renal tumor cells in vitro. J Pediatr Surg 35: 884-890, 2000.
22. Orlov SN, Tremblay J, and Hamet P. Cell volume in vascular smooth muscle is regulated by bumetanide-sensitive ion transport. Am J Physiol Cell Physiol 270: C1388-C1397, 1996.
23. Polyak K, Waldman T, He TC, Kinzler KW, and Vogelstein B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 10: 1945-1952, 1996.
24. Record IR, Broadbent JL, King RA, Dreosti IE, Head RJ, and Tonkin AL. Genistein inhibits growth of B16 melanoma cells in vivo and in vitro and promotes differentiation in vitro. Int J Cancer 72: 860-864, 1997.
25. Ritter D, Chao J, Needleman P, Tetens E, and Greenwald JE. Localization, synthetic regulation, and biology of renal atriopeptin-like prohormone. Am J Physiol Renal Fluid Electrolyte Physiol 263: F503-F509, 1992.
26. Ritter D, Needleman P, and Greenwald JE. Synthesis and secretion of an atriopeptin-like protein in rat kidney cell culture. J Clin Invest 87: 208-212, 1991.
27. Schlingensiepen KH, Schlingensiepen R, Kunst M, Klinger I, Gerdes W, Seifert W, and Brysch W. Opposite functions of jun-B and c-jun in growth regulation and neuronal differentiation. Dev Genet 14: 305-312, 1993.
28. Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, and Forssmann WG. Isolation and structural analysis of "urodilatin," a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr 66: 752-759, 1988.
29. Schürch W, Bégin LR, Seemayer TA, Lagacé R, Boivin JC, Lamoureux C, Bluteau P, Piche J, and Gabbiani G. Pleomorphic soft tissue myogenic sarcomas of adulthood. A reappraisal in the mid-1990s. Am J Surg Pathol 20: 131-147, 1996.
30. Solban N, Dumas P, Gossard F, Sun Y, Pravenec M, Kren V, Lewanczuk R, Hamet P, and Tremblay J. Chromosomal mapping of HCaRG, a novel hypertension-related, calcium-regulated gene. Folia Biol (Praha) 48: 9-14, 2002.
31. Solban N, Jia HP, Richard S, Tremblay S, Devlin AM, Peng J, Gossard F, Guo DF, Morel G, Hamet P, Lewanczuk R, and Tremblay J. HCaRG, a novel calcium-regulated gene coding for a nuclear protein, is potentially involved in the regulation of cell proliferation. J Biol Chem 275: 32234-32243, 2000.
32. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, and Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704, 1993.
33. Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL, and Ron D. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12: 982-995, 1998.
34. Zwicker J, Lucibello FC, Wolfraim LA, Gross C, Truss M, Engeland K, and Muller R. Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J 14: 4514-4522, 1995.